Haematological: anaemia, disturbances of blood count, including differential white cell count, leukopenia and thrombocytopenia. Concomitant administration of a potentially myelotoxic drug, in particular methotrexate, appears to be a predisposing factor to the onset of a cytopenia.
Dermatological: pruritus, skin rash, stomatitis, urticaria, photosensitisation. On rare occasions bullous reactions, erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis may develop.
Respiratory: cough, pharyngitis, upper respiratory infection, onset of acute asthma has been reported in certain individuals following the administration of aspirin or other NSAIDs, including MELOX.
Central nervous system: lightheadedness, headache, vertigo, tinnitus, drowsiness, insomnia.
Cardiovascular: oedema, increase of blood pressure, palpitations, flush.
Genitourinary: abnormal renal function parameters (increased serum creatinine and/or serum urea), acute renal failure.
Vision disorders: conjunctivitis, visual disturbances including blurred vision.
Other: Flu-like symptoms.
View ADR Reporting Link
Sign Out